Charlotte Schubert / GeekWire
Juno Therapeutics vets Steve Harr and Hans Bishop on building startups, working with tech, and more – Hans Bishop and Steve Harr know a few things about biotech. The pair once worked together at Seattle flagship cell therapy company Juno Therapeutics, where Bishop was CEO and Harr was COO and CFO. After Juno was acquired by Celgene in 2018 for more than $9 billion, Bishop and Harr …
